GILEAD SCIENCES, INC. Executive Compensation

Named executive officer pay as disclosed in the company’s 2026-03-20 proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.

$28,437,198

Daniel P, Chief Executive Officer — total compensation

Healthcare

industry

Executive	Title	Base salary	Total compensation
Daniel P	O’Day Chairman and Chief Executive Officer	—	$28,437,198
Johanna Mercier	Chief Commercial and Corporate Affairs Officer	—	$9,300,643
Andrew D. Dickinson	Chief Financial Officer	—	$8,765,616
Deborah H. Telman	Former Executive Vice President, Corporate Affairs and General Counsel	—	$5,004,669

Source: GILEAD SCIENCES, INC. Definitive Proxy Statement (DEF 14A), filed 2026-03-20 with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.